Indication

Hyperparathyroidism secondary to chronic renal failure

Hyperparathyroidism secondary to chronic renal failure is a systemic mineral and endocrine disorder characterized by excessive parathyroid hormone secretion and parathyroid gland hyperplasia occurring in response to declining kidney function. Read more about Hyperparathyroidism secondary to chronic renal failure

51 drugs 35 manufacturers

Advertisement

Drugs that treat it

Common Hyperparathyroidism secondary to chronic renal failure therapies.

Showing 1–9 of 51 drugs

Filter & compare in the drug finder →Opens the drug finder with Hyperparathyroidism secondary to chronic renal failure preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Hyperparathyroidism secondary to chronic renal failure.

Hyperparathyroidism secondary to chronic renal failure is a systemic mineral and endocrine disorder characterized by excessive parathyroid hormone secretion and parathyroid gland hyperplasia occurring in response to declining kidney function.

Pathophysiologically, deteriorating renal clearance causes phosphate retention, reduced synthesis of active 1,25-dihydroxyvitamin D (calcitriol), and resultant hypocalcemia, which continuously stimulate the parathyroid glands.

If unmanaged, this chronic hormonal and biochemical dysregulation affects the skeletal and cardiovascular systems, contributing to renal osteodystrophy, bone fractures, and vascular calcification.

Personalize your experience

Follow Hyperparathyroidism secondary to chronic renal failure and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it